Research programme: G-protein coupled receptor modulators - ConfometRx/UCB
Latest Information Update: 16 Jul 2016
At a glance
- Originator ConfometRx; UCB
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Neurological-disorders in Belgium
- 16 Jul 2016 No recent reports of development identified for research development in Neurological-disorders in USA
- 01 Feb 2016 ConfometRx has patent protection for fusion-protein technology